Home Cart 0 Sign in  

[ CAS No. 1264097-17-7 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 1264097-17-7
Chemical Structure| 1264097-17-7
Structure of 1264097-17-7 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 1264097-17-7 ]

Related Doc. of [ 1264097-17-7 ]

Alternatived Products of [ 1264097-17-7 ]

Product Details of [ 1264097-17-7 ]

CAS No. :1264097-17-7 MDL No. :MFCD18425906
Formula : C10H12ClN3 Boiling Point : -
Linear Structure Formula :- InChI Key :OVTDGUKFHSTJRM-UHFFFAOYSA-N
M.W : 209.68 Pubchem ID :50944209
Synonyms :

Calculated chemistry of [ 1264097-17-7 ]

Physicochemical Properties

Num. heavy atoms : 14
Num. arom. heavy atoms : 11
Fraction Csp3 : 0.1
Num. rotatable bonds : 2
Num. H-bond acceptors : 1.0
Num. H-bond donors : 1.0
Molar Refractivity : 59.35
TPSA : 43.84 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : Yes
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.19 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.0
Log Po/w (XLOGP3) : 1.95
Log Po/w (WLOGP) : 2.32
Log Po/w (MLOGP) : 1.45
Log Po/w (SILICOS-IT) : 1.12
Consensus Log Po/w : 1.37

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.82
Solubility : 0.319 mg/ml ; 0.00152 mol/l
Class : Soluble
Log S (Ali) : -2.5
Solubility : 0.67 mg/ml ; 0.0032 mol/l
Class : Soluble
Log S (SILICOS-IT) : -2.97
Solubility : 0.226 mg/ml ; 0.00108 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.7

Safety of [ 1264097-17-7 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 1264097-17-7 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 1264097-17-7 ]

[ 1264097-17-7 ] Synthesis Path-Downstream   1~4

  • 1
  • [ 1264097-17-7 ]
  • [ 203436-45-7 ]
  • N-(1-benzyl-1H-pyrazol-4-yl)-2-chloro-9-(propan-2-yl)-9H-purin-6-amine [ No CAS ]
YieldReaction ConditionsOperation in experiment
2.3 g With N-ethyl-N,N-diisopropylamine; In isopropyl alcohol; at 100.0℃; for 2.0h; A mixture of l-benzyl- lH-pyrazol-4-amine hydrochloride (2.43 g, 11.59 mmol, 1.20 equiv), 2,6-dichloro-9-(propan-2-yl)-9H-purine (2.23 g, 9.65 mmol, 1.00 equiv) and DIEA (1.24 g, 9.59 mmol, 0.99 equiv) in propan-2-ol (30 mL) was stirred for 2 h at 100 C in an oil bath. The resulting mixture was concentrated under vacuum. The residue was purified on a silica gel column with ethyl acetate/petroleum ether (1/1) to afford 2.3 g (65%) of N-(l -benzyl- 1H- pyrazol-4-yl)-2-chloro-9-(propan-2-yl)-9H-purin-6-amine as a dark red solid.
  • 2
  • [ 1055407-79-8 ]
  • [ 1264097-17-7 ]
  • N-(1-benzyl-1H-pyrazol-4-yl)-2-chloro-9-(2-methylpropyl)-9H-purin-6-amine [ No CAS ]
YieldReaction ConditionsOperation in experiment
With N-ethyl-N,N-diisopropylamine; In isopropyl alcohol; at 100.0℃; for 6.0h; A mixture of l-benzyl-lH-pyrazol-4-amine hydrochloride (510 mg, 2.43 mmol, 1.19 equiv), 2,6-dichloro-9-(2-methylpropyl)-9H-purine (500 mg, 2.04 mmol, 1.00 equiv), i-propanol (5 mL) and DIEA (1.05 g, 8.12 mmol, 3.98 equiv) was stirred for 6 h at 100C in an oil bath. The resulting mixture was concentrated under vacuum to remove the solvents. The residue was purified on a silica gel column with dichloromethane/methanol (100/1) to afford 600 mg (crude) of N-(l-benzyl-lH-pyrazol-4-yl)-2-chloro-9-(2-methylpropyl)-9H-purin-6-amine as a dark red solid.
  • 3
  • 2,6-dichloro-9-cyclobutyl-9H-purine [ No CAS ]
  • [ 1264097-17-7 ]
  • N-(1-benzyl-1H-pyrazol-4-yl)-2-chloro-9-cyclobutyl-9H-purin-6-amine [ No CAS ]
YieldReaction ConditionsOperation in experiment
61% With triethylamine; In isopropyl alcohol; at 80.0℃; for 12.0h; A mixture of 2,6-dichloro-9-cyclobutyl-9H-purine (500 mg, 2.06 mmol, 1.00 equiv), 1- benzyl-lH-pyrazol-4-amine hydrochloride (250 mg, 1.19 mmol, 1.20 equiv), triethylamine (250 mg, 2.48 mmol, 1.20 equiv) in 20 mL of IPA was stirred for 12 h at 80 C. The resulting mixture was concentrated under vacuum. The residue was dissolved in 50 mL of ethyl acetate. The resulting mixture was washed with 3x30 mL of NH4C1. The resulting solution was dried over anhydrous sodium sulfate and concentrated under vacuum. This resulted in 476 mg (61%) of N-(l-benzyl-lH-pyrazol-4-yl)-2-chloro-9-cyclobutyl-9H-purin-6-amine as an orange solid.
  • 4
  • [ 1264097-17-7 ]
  • [ 54916-66-4 ]
  • N-(1-benzyl-1H-pyrazol-4-yl)-5-bromo-2-methoxynicotinamide [ No CAS ]
YieldReaction ConditionsOperation in experiment
90% With (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate; N-ethyl-N,N-diisopropylamine; In N,N-dimethyl-formamide; at 20℃; for 2h; A mixture of <strong>[54916-66-4]5-bromo-2-methoxynicotinic acid</strong> (500 mg, 2.155 mmol), 1-benzyl-1H-pyrazol-4- amine, HCl (452 mg, 2.155 mmol), Huenig's base (1.129 mL, 6.46 mmol) and BOP (1144 mg, 2.59 mmol) in DMF (5 mL) was stirred at rt for 2 h. The reaction mixture was diluted with water, extracted with EtOAc, dried over MgSO4, filtered and concentrated to obtain N-(1-benzyl-1H-pyrazol-4-yl)-5-bromo-2-methoxynicotinamide (750 mg, 1.937 mmol, 90 % yield) as an oil. (0887) MS ESI m/z 388.76 (M+H). (0888) 1H NMR (400 MHz, CDCl3) delta 9.76 - 9.34 (m, 1H), 8.70 - 8.57 (m, 1H), 8.44 - 8.31 (m, 1H), 7.65 - 7.60 (m, 1H), 7.42 - 7.29 (m, 5H), 5.36 - 5.31 (m, 2H), 4.21 - 4.17 (m, 3H).
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 1264097-17-7 ]

Aryls

Chemical Structure| 28466-62-8

[ 28466-62-8 ]

1-Benzyl-1H-pyrazol-4-amine

Similarity: 0.98

Chemical Structure| 1107632-13-2

[ 1107632-13-2 ]

(4-(1H-Pyrazol-1-yl)phenyl)methanamine hydrochloride

Similarity: 0.81

Chemical Structure| 20157-44-2

[ 20157-44-2 ]

1-(o-Tolyl)-1H-pyrazole

Similarity: 0.80

Chemical Structure| 687635-04-7

[ 687635-04-7 ]

(3-(1H-Pyrazol-1-yl)phenyl)methanamine

Similarity: 0.79

Chemical Structure| 368870-03-5

[ 368870-03-5 ]

(4-(1H-Pyrazol-1-yl)phenyl)methanamine

Similarity: 0.79

Amines

Chemical Structure| 28466-62-8

[ 28466-62-8 ]

1-Benzyl-1H-pyrazol-4-amine

Similarity: 0.98

Chemical Structure| 1107632-13-2

[ 1107632-13-2 ]

(4-(1H-Pyrazol-1-yl)phenyl)methanamine hydrochloride

Similarity: 0.81

Chemical Structure| 687635-04-7

[ 687635-04-7 ]

(3-(1H-Pyrazol-1-yl)phenyl)methanamine

Similarity: 0.79

Chemical Structure| 368870-03-5

[ 368870-03-5 ]

(4-(1H-Pyrazol-1-yl)phenyl)methanamine

Similarity: 0.79

Chemical Structure| 947763-34-0

[ 947763-34-0 ]

1-Ethyl-3-methyl-1H-pyrazol-4-amine

Similarity: 0.70

Related Parent Nucleus of
[ 1264097-17-7 ]

Pyrazoles

Chemical Structure| 28466-62-8

[ 28466-62-8 ]

1-Benzyl-1H-pyrazol-4-amine

Similarity: 0.98

Chemical Structure| 1107632-13-2

[ 1107632-13-2 ]

(4-(1H-Pyrazol-1-yl)phenyl)methanamine hydrochloride

Similarity: 0.81

Chemical Structure| 20157-44-2

[ 20157-44-2 ]

1-(o-Tolyl)-1H-pyrazole

Similarity: 0.80

Chemical Structure| 687635-04-7

[ 687635-04-7 ]

(3-(1H-Pyrazol-1-yl)phenyl)methanamine

Similarity: 0.79

Chemical Structure| 368870-03-5

[ 368870-03-5 ]

(4-(1H-Pyrazol-1-yl)phenyl)methanamine

Similarity: 0.79